ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Program Manager, Drug Development at Mirum Pharmaceuticals - ApplyBlast

Senior Program Manager, Drug Development

Mirum Pharmaceuticals

2 days ago

4.0 on Glassdoor

Foster City, California, United States

Hybrid

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Senior Program Manager, Drug Development partners with the Program Lead and cross-functional teams to shape and execute integrated program strategy and long-range plans from preclinical development through commercialization. This role drives team alignment and disciplined execution across scope, schedule, risks, budget, and stakeholder communications. The position connects research, CMC, clinical, regulatory, and commercial functions to ensure coordinated delivery of key program milestones.

Responsibilities

Lead integrated program planning and execution for drug development programs
Establish and maintain functionally integrated program schedules and critical path analysis
Identify, assess, and track program risks and issues with mitigation planning

Skills

Qualifications

BA/BS in a life sciences disciplinemaster's degreePhD degreePMP certification

About Mirum Pharmaceuticals

mirumpharma.com

Headquarters

Foster City, California, United States

Company Size

201-500 employees

Founded

2018

View Profile

Mirum Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing patient-inspired therapies for rare diseases where unmet medical need is greatest. The company has three approved medicines and a broad pipeline of investigational therapies spanning multiple rare disease areas, including cholestatic liver diseases and conditions such as Fibrodysplasia Ossificans Progressiva. Mirum combines deep rare disease expertise with regulatory strategy and patient access considerations to deliver meaningful treatments to small, high-need patient populations worldwide.